Radiopharmaceutical diagnosis of Erdheim–Chesterʼs disease

Erdheim–Chesterʼs disease is a non-inherited multi-focal lipid-storing histiocytosis of unknown origin without a complete and convincing diagnostic and therapeutic protocol. We have previously suggested diagnostic methods using radioisotopes to evaluate this disseminating disease, but they are neith...

Full description

Saved in:

Bibliographic Details
Published in:	Nuclear medicine communications Vol. 28; no. 1; pp. 63 - 65
Main Authors:	Palotás, András, Bogáts, Gábor, Lázár, Máté, Papós, Miklós, Matin, Keyvan, Pávics, László
Format:	Journal Article
Language:	English
Published:	England Lippincott Williams & Wilkins, Inc 01-01-2007
Subjects:	Bone and Bones - diagnostic imaging Erdheim-Chester Disease - diagnosis Erdheim-Chester Disease - diagnostic imaging Granulocytes - metabolism Humans Male Middle Aged Organophosphorus Compounds - pharmacology Organotechnetium Compounds - pharmacology Radiopharmaceuticals Tomography, Emission-Computed, Single-Photon - methods Whole Body Imaging
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Erdheim–Chesterʼs disease is a non-inherited multi-focal lipid-storing histiocytosis of unknown origin without a complete and convincing diagnostic and therapeutic protocol. We have previously suggested diagnostic methods using radioisotopes to evaluate this disseminating disease, but they are neither specific nor selective in this regard. The present hypothesis-driven paper reviewing our case proposes novel approaches involving nuclear medicine and utilizing radiopharmaceuticals to identify this potentially fatal multi-system disease.
Bibliography:	ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3
ISSN:	0143-3636
DOI:	10.1097/MNM.0b013e328013dcd3